Antibody-antigen docking performance on par with AlphaFold3

Learn MoreIntroducing GeoFlow: Next-Gen Generative Model for Antibody Modeling and Design

Both parties will create a next-generation AIGC-driven antibody drug discovery platform jointly and promote tripartite cooperation with significant innovative drug companies or biotech firms to enhance the efficiency of new drug R&D and help pharmaceutical R&D enterprises improve their global competitiveness.

Learn MoreBioGeometry Joins Hands with Sanyou to Build a New Generation AIGC-Driven Antibody Drug Discovery Platform

Both parties will fully leverage their respective strengths in a comprehensive strategic collaboration within the field of large molecule pharmaceuticals, aiming to achieve breakthrough progress in antibody drug R&D through the application of AI technology.

Learn MoreBioGeometry Announces Strategic Cooperation with Symray Biopharma for the Large Molecule Drug R&D

The two parties will engage in deep collaboration on platform products, project optimization services, and resource expansion to promote innovation together in antibody research and development, providing pharmaceutical clients with higher-quality R&D services.

Learn MoreBioGeometry and BioMetas Join Hands to Empower Development of Novel Large Molecule Drugs

Both companies are dedicated to constructing a large multimodal model（LMM）that aligns human natural language with the language of life.

Learn MoreBioGeometry and Zhipu AI Establish Strategic Cooperation to Building a Large Multimodal Model between Human Language and Biological Language

Together, they aim to lead the digital biology industry’s ecosystem construction, making AI technology platforms more efficient and convenient to aid biopharmaceutical research and development.

Learn MoreBioGeometry Announces a Cooperation Agreement with Aliyun to Jointly Explore the Global Digital Biology Market

BioGeometry as a rising star in AI-driven large molecule biomedicine and a partner of Aliyun in the healthcare and biopharmaceutical industry, was invited to participate the 2023 Apsara Conference.

Learn MoreBioGeometry Showcased AI-Driven Biologics Platform at Apsara Conference

Pushing the frontiers of AI x BioMed

Learn MoreJian’s Keynote at 2023 BAAI Conference: Foundation Models for Protein Modeling

Latest research updates from BioGeometry and Mila Team

Learn More5 Papers Accepted by ICLR’23

Key pharmaceutical and health project in Zhongguancun Tech Hub signed

Learn MoreBioGeometry Signs Key Project at the 25th Beijing-HK Symposium